Latest posts
-
GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Upgrading at Ecuador Center (GKCE) with State-of-the-Art Gamma Knife ICON
Upgrade of Gamma Knife® 4C with NEW Elekta ICON for most precise and accurate treatment of Intracranial cancers and other indications SAN FRANCISCO, Nov. 28, 2023 – GK Financing LLC (GKF), a subsidiary of American Shared Hospital Services (NYSE American: AMS), a leading provider of creative financial and turnkey technology solutions for advanced radiosurgery and
-
PRISM MarketView Spotlights Significant Market Opportunities in Global Health with Launch of Emerging Public Health Index
NEW YORK, NY, November 14, 2023 – PRISM MarketView, a leader within the financial markets and news community, has debuted its PRISM Emerging Public Health Index. The Public Health segment highlights the most critical health crises impacting the world’s population today – including dementia, diabetes, stroke, hypertension and heart disease – as identified by the
-
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
Company to Host a Conference Call and Webcast on November 14, 2023, at 10:30 am EDT POMPANO BEACH, FLORIDA, November 13, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the quarter ended September 30, 2023. Jason Matuszewski,
-
PRISM MediaWire – Weekly Press Resume – Nov. 6 to Nov. 10, 2023
New York, New York, Nov. 10, 2023 PRISM MediaWire – Weekly Press Resume Nov. 6 to Nov. 10, 2023 Two Hands Corporation Launches Sports Illustrated Line Protein Bars in Canada BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023 Evergreen Group unveils new corporate haven in M’sia with HWG partnership
-
Oncocyte Reports Third Quarter 2023 Financial Results
-Launching First Products in 1H 2024- -Conference Call on Thursday, November 9, 2023, at 5:00 a.m. PT / 8:00 a.m. ET- IRVINE, CA, November 09, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today reported financial results for the third quarter of 2023, ended September 30, 2023. Third Quarter and Recent Highlights Josh Riggs, CEO
-
BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
POMPANO BEACH, FLORIDA, November 6, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today that it plans to release its third quarter 2023 financial results pre-market on Tuesday, November 14, 2023. BioStem will host a